Access Landscape

A review of pivotal developments across basic medical insurance, commercial health insurance, and the provider sector—shaping pricing, reimbursement, and access to innovative medicines.

Jun

Understanding China’s Access Environment for Orphan Therapies: Advancing Policies and Diagnosis & Treatment Capacities

In our previous installment, we delved into the distinctive characteristics and commercial challenges surrounding rare diseases, highlighting a comprehensive solution

Jun 7, 2023

10 min read

May

Understanding China’s Access Environment for Orphan Therapies: 3 Key Considerations

Biopharmaceutical companies face distinctive challenges when it comes to developing and commercializing treatments for rare diseases, as these conditions affect

May 24, 2023

6 min read